by Georgi Ivanov | Sep 9, 2024 | Blog
This year’s European Society of Cardiology (ESC) Congress highlighted a narrative shift in cardiology, with prevention and detection gaining more prominence and overshadowing the traditional focus on treatment and management. A change in perspective...
by Sofia Tzamarelou | Jul 23, 2024 | Blog
Pharma PR and comms need new strategies to reduce the stigma around lung cancer, which gets in the way of screening rates and drug development. Lung cancer has a branding problem More people die from lung cancer than any other cancer, and it kills more women than...
by Georgi Ivanov | Jun 10, 2024 | Blog
ASCO’s focus on less invasive treatment suggests a narrative shift in oncology: that doing less — less surgery, less chemotherapy or less radiation — can help patients live longer and feel better. The context: The 2024 edition of the American Society of Clinical...
by Christina Arshadi | Apr 23, 2024 | Blog
As healthcare communicators have struggled to combat statin misinformation with traditional debunking strategies, our study reveals how “pre-bunking” can be much more effective. The context: While statins – the most popular class of...
by Maya Koleva | Mar 13, 2024 | Blog
Reading time: 3 min As US drug pricing negotiations are making headlines every day, our analysis found that pharma’s reputation is suffering mainly because of media misconceptions that companies can clear out. What we found: Our study of 1,705 English-language...
